| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 304.157 | 316.972 | - | 333.170 | 304.344 | 323.733 | 327.560 | 272.386 | 249.357 | 216.620 |
| Total Income - EUR | 308.060 | 320.511 | - | 337.815 | 308.584 | 324.571 | 327.894 | 273.237 | 249.434 | 222.428 |
| Total Expenses - EUR | 305.745 | 271.495 | - | 326.658 | 292.322 | 305.687 | 288.179 | 250.309 | 241.032 | 219.200 |
| Gross Profit/Loss - EUR | 2.315 | 49.016 | - | 11.157 | 16.261 | 18.884 | 39.715 | 22.928 | 8.402 | 3.229 |
| Net Profit/Loss - EUR | 1.945 | 41.174 | - | 7.812 | 13.170 | 15.933 | 36.501 | 20.195 | 6.121 | 2.747 |
| Employees | 0 | 0 | - | 24 | 22 | 16 | 16 | 14 | 13 | 11 |
Check the financial reports for the company - Explomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 154.811 | 146.121 | - | 154.181 | 155.801 | 138.053 | 130.222 | 132.271 | 119.660 | 110.340 |
| Current Assets | 41.013 | 63.389 | - | 72.535 | 89.937 | 148.052 | 155.717 | 121.313 | 94.810 | 126.074 |
| Inventories | 0 | 0 | - | 4.539 | 9.487 | 17.833 | 21.648 | 24.443 | 24.560 | 17.481 |
| Receivables | 23.622 | 27.273 | - | 57.141 | 68.237 | 98.416 | 105.312 | 84.051 | 65.211 | 106.792 |
| Cash | 17.391 | 36.116 | - | 10.854 | 12.213 | 31.802 | 28.757 | 12.819 | 5.039 | 1.800 |
| Shareholders Funds | 48.610 | 89.288 | - | 12.035 | 17.322 | 32.926 | 55.767 | 84.020 | 89.886 | 92.665 |
| Social Capital | 112 | 111 | - | 107 | 105 | 103 | 101 | 101 | 101 | 101 |
| Debts | 136.499 | 120.234 | - | 232.945 | 300.471 | 287.055 | 296.464 | 305.059 | 302.633 | 332.469 |
| Income in Advance | 168 | 7.359 | - | 954 | 0 | 0 | 0 | 0 | 0 | 508 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Explomed Srl